The efficacy of NAFL in the treatment of striae distensae (SD) has been demonstrated. Nevertheless, the base for this improvement has not been clarified yet. The aim of this study is to describe in vivo variations occurring in the skin after the treatment, using reflectance confocal microscopy (RCM). Ten patients asking for the treatment of SD were enrolled. Clinical and RCM images were acquired before the treatment, immediately after 1 and 6 months after the first treatment. One thousand five hundred forty-nanometer laser treatments were performed every 4 weeks for 6 sessions. Efficacy was estimated through the evaluation of pre- and post-treatment clinical pictures by two expert and independent physicians and with GAIS. Improvement of SD was observed in 80% of patients. Temporary erythema and edema were reported. RCM revealed the dissolution of collagen bundles and the appearance of new papillae, as compared to baseline. NAFL represents an effective and safe treatment modality for SD. We report herein in vivo variations occurring in SD after NAFL treatment.
1. Four women suffering from senile osteoporosis have been treated for 55-60 days with 25 MRC Units per day of porcine thyrocalcitonin with the following metabolic results : (a) slight diminution of plasma, urinary and endogenous faecal calcium levels ; (b) slight diminution of plasma phosphate level and urinary phosphate clearance ; (c) lowering of serum alkaline phosphatase values ; (d) diminution of urinary hydroxyproline excretion ; (e) modification of calcium balance toward positive, due to decreased urinary 2. 47Calcium kinetic studies demonstrated: (a) a slower decline in the specific activity curve after thyrocalcitonin treatment; (b) a slower decline in bone uptake values; (c) a decrease of 'calcium miscible pool', 'calcium turnover rate', 'accretion rate' 3. Differences in radiological bone patterns were not observed despite an improve-and faecal calcium and to an improvement in intestinal absorption. and 'resorption rate' calculated by the method of Aubert & Milhaud (1960). ment in the pain after treatment.The possibility that thyrocalcitonin may be of clinical value in senile osteoporosis is of great interest, but its use in this condition has been studied only for short periods in a limited number of subjects (Foster et al., 1968). More recently Baud et al. (1969) reported histological changes after 4 weeks treatment of three osteoporotic patients : diminution of enlarged osteocytes, increase of small osteocytes and of highly mineralized areas of bone. This paper reports the result of metabolic studies in four women suffering from senile osteoporosis who were treated with thyrocalcitonin for 55-60 days.
Background and Objectives: The efficacy of picosecond laser (PSL) in the treatment of striae distensae (SD) has been recently reported; otherwise, the base for this improvement has not been clarified yet. The aim of this study is to treat long-lasting SD with PLS and to describe their in vivo morphological variations after treatment using three-dimensional (3D) imaging and reflectance confocal microscopy (RCM). Study Design/Materials and Methods: A total of 27 patients asking for treatment for SD were treated with four monthly sessions of PLS. Clinical improvement was estimated through a blinded evaluation performed by two independent dermatologists, Global Assessment Improvement Scale (GAIS), patients′ satisfaction, 3D imaging, and RCM assessments at baseline and 6 months after the last laser session. Results: Although a clinical improvement of SD was observed in 81.4% of patients according to physicians′ GAIS, only 66.6% of patients reported subjective improvement and satisfaction after treatment (P = 0.04). 3D imaging revealed a significant improvement in terms of skin texture (P < 0.001) and mean SD depth (P < 0.001). Otherwise, RCM highlighted collagen remodeling and the appearance of new dermal papillae in all the treated SD compared with baseline. Conclusions: The present study confirms that PLS represents a safe treatment option for SD; herein, we report morphological documentation of skin variations after PLS treatment. Lasers Surg. Med.
Background The aging of facial structures depends on genetic, anatomic, chronologic, and environmental factors that affect the skin and underlying tissues. Microfocused ultrasound with visualization (MFU‐V) has emerged as a safe and effective treatment for skin laxity. As the nutritional status may contribute to skin aging, it would be interesting to evaluate whether different dietary patterns can also influence the response to MFU‐V treatment for skin laxity. Aims The aim of this study is to compare the outcome of MFU‐V therapy between omnivore and vegan patients. Methods Twenty‐seven vegan and twenty‐seven omnivorous women who underwent MFU‐V treatment for laxity of lower face and neck were enrolled. The clinical outcome was evaluated using the FLR (Facial Laxity Rating) scale after 3 and 6 months from treatment. Results At baseline, no significant differences were found in terms of FLR scale in both treated sites. After 3 months, reduction in FLR scale was significantly lower for vegans both on face (P = .04) and neck (P = .004). At 6 months, vegan patients had a worse clinical outcome on lower face (P = .001) and neck (P < .001). Conclusion The present study suggests that a vegan diet may negatively influence the outcome of a MFU‐V treatment.
So wird man Warzen dauerhaft los Warzen sind lästig. Trotz erfolgreicher Behandlung kommen sie häufig wieder. Wie lässt sich das Rückfallrisiko am besten minimieren?
The efficacy of laser for treatment of telangiectasias of the face has been previously proven. Nevertheless, this is the first study presenting an analysis of risk factors involved in the new appearance of telangiectasias after the clearance induced by therapy.
BACKGROUND Postsurgical skin healing can result in different scars types, ranging from a fine line to pathologic scars, in relation to patients' intrinsic and extrinsic factors. Although the role of nutrition in influencing skin healing is known, no previous studies investigated if the vegan diet may affect postsurgical wounds. OBJECTIVE The aim of this study was to compare surgical scars between omnivore and vegan patients. METHODS AND MATERIALS This is a prospective observational study. Twenty-one omnivore and 21 vegan patients who underwent surgical excision of a nonmelanoma skin cancer were enrolled. Postsurgical complications and scar quality were evaluated using the modified Scar Cosmesis Assessment and Rating (SCAR) scale. RESULTS Vegans showed a significantly lower mean serum iron level (p < .001) and vitamin B12 (p < .001). Wound diastasis was more frequent in vegans (p = .008). After 6 months, vegan patients had a higher modified SCAR score than omnivores (p < .001), showing the worst scar spread (p < .001), more frequent atrophic scars (p < .001), and worse overall impression (p < .001). CONCLUSION This study suggests that a vegan diet may negatively influence the outcome of surgical scars.
Sir; A poor intestinal absorption of phosphate is a possible factor in the pathogenesis of osteomalacia and hypophosphataemic rickets [1,9,11], and evidence of improvement of pseudofractures on long-term oral phosphate treatment has been given recently [4,8]. The intestinal absorption of radiophosphate has been studied in animals [5,6,7,10], and recently in human subjects [2,3]. The test for evaluating the intestinal absorption of radiophosphate is based on the oral administration of 50 microcuries of Na2Ha2P04 and measuring the plasma radioactivity levels, expressed as the percentage of dose per litre of plasma, in the 4 h after the administration of the dose. We have tested by this method 2 cases of nutritional osteomalacia and a case of hypophosphataemic rickets; basal conditions showed low levels of plasma radioactivity in 2 cases (T. M. and G. C.) and normal levels in the third case (B. R.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.